Hypereosinophilic Syndrome NFZ — 23 facilities in 20 cities

Hypereosinophilic syndrome involves chronically elevated eosinophil counts in the blood, which can damage the heart, lungs, skin, and nervous system. The NFZ covers hematological and immunological diagnostics, corticosteroid treatment, hydroxyurea, and mepolizumab therapy through drug programs. It is important to rule out other causes of eosinophilia such as allergies or parasitic infections.